Oakridge International reported a $267,000 operating cash outflow for the September quarter, leaving $343,000 in cash and an estimated 1.28 quarters of funding. The healthcare technology company expects collections and customer orders to improve cash flow, while evaluating additional funding and continuing to manage a potential historical claim from Teko International.
- $461,000 in customer receipts for the quarter
- $267,000 net operating cash outflow
- $343,000 cash balance at 30 September
- Estimated funding runway of 1.28 quarters
- Additional funding options under evaluation
Cash runway falls below two quarters
Oakridge International Limited (ASX:OAK) has less than two quarters of estimated funding available after recording a $267,000 net operating cash outflow in the three months to 30 September 2026. The healthcare technology company ended the period with $343,000 in cash and reported an estimated funding runway of 1.28 quarters.
Customer receipts came to $461,000, down from $585,000 in the corresponding quarter of 2025. Against that inflow, Oakridge paid $350,000 in staff costs, $187,000 in product manufacturing and operating costs, and $169,000 in administration and corporate costs. Related-party payments, primarily director and executive fees, totalled $40,665.
Funding plans depend on cash flow improvement
Oakridge said it expects net operating cash flows to increase over the next two quarters, citing inventory investment, the collection of receivables, a pipeline of customer orders and growing enquiries. Those are expectations rather than reported cash outcomes: the quarter itself produced a negative operating result, and the company said it is evaluating options to obtain additional funds.
The Appendix 4C records no drawn loan or other financing facility at quarter-end. Its cash reconciliation shows bank balances falling from $638,000 in the previous quarter to $343,000 at 30 September. However, the cash-flow table also presents a $638,000 net increase figure alongside the $638,000 opening balance and $343,000 closing balance, an apparent internal inconsistency that investors may want clarified.
Project pipeline remains active but unconverted
Operationally, Oakridge described project delivery and partner activity as continuing across aged care, disability care, hospitals, retirement living and supported independent living. Installations progressed across multiple sites, while the active quote book included larger opportunities awaiting purchase orders, final approvals or delivery scheduling.
The company’s sales narrative has improved over the past year, including the prior-year Q1 receipts marker, but the September quarter shows the immediate tension: a pipeline can support future revenue only once opportunities convert into orders, deliveries and collections. Oakridge said current channel activity and qualified opportunities are expected to support revenue through FY2027, though no contract wins or revenue guidance were announced in this update.
RTLS and software development continue
Product work continued on real-time location systems, enterprise reporting, mobile applications, single sign-on configuration and annunciator firmware. Oakridge also progressed planning for LCD annunciators, nurse-station monitor integration, sign-in and sign-out tools and a new call-point specification, alongside readiness work for ISO 9001:2015 and ISO 27001-related certification.
The company also repeated its disclosure about a potential claim from Teko International relating to alleged misrepresentations concerning unrecorded liabilities. Oakridge’s board said there may be exposure, but the announcement provides no current claim amount, litigation timetable or indication that proceedings have commenced. The issue has remained part of the company’s risk profile since earlier disclosures, including Teko legal discussions.
Bottom Line?
The next two quarters need to show that receivables, inventory investment and quoted projects can translate into cash before the 1.28-quarter runway becomes more pressing.
Questions in the middle?
- Will Oakridge secure additional funding before its available cash approaches the end of the stated runway?
- How much of the active quote book will convert into purchase orders and collected revenue over the next two quarters?
- Can the company clarify the inconsistent cash movement figures and provide greater visibility on the potential Teko claim?